Canadian pharma wins licence dispute as another continues
A Canadian pharmaceuticals company has defeated an ICC claim brought against it by an Irish counterpart over the marketing of a drug used to treat a chronic intestinal condition, as a separate US$365 million claim it faces from an Italian company continues.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10